To test for lung cancer, a person needs to get low-dose computed tomography screening, more commonly known as a CT scan. But that can be costly and time-consuming, just two reasons why less than 2% of ...
Lung cancer is the second most common cancer in the United States and is the leading cause of death from cancer. If lung cancer is found early, when it is small and before it has spread, it is more ...
bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW),a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, today announced that Chief Medical Officer ...
BURLINGTON, Mass. and PALO ALTO, Calif., Nov. 19, 2024 /PRNewswire/ -- DELFI Diagnostics, Inc., a developer of accessible blood-based tests that deliver a new way to enhance cancer detection, has ...
The Oncomine Dx Target Test assesses tumor samples for the presence of biomarkers associated with three drug therapies approved to treat non-small cell lung cancer. Physicians can use the test to ...
With a San Antonio biotech firm’s test, your phlegm could help save you from cancer. The screening method developed by bioAffinity Technologies Inc. uses AI-aided computer analysis of a patient’s ...
What are pulmonary function tests? Pulmonary function tests (PFTs) are tests of lung function. They are intended to evaluate and monitor chronic obstructive pulmonary disease (COPD). COPD is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback